REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 120 filers reported holding REVOLUTION MEDICINES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,221,398 | +11.6% | 766,669 | +7.8% | 0.01% | +20.0% |
| Q2 2023 | $19,022,219 | +33.6% | 711,111 | +8.2% | 0.01% | +25.0% |
| Q1 2023 | $14,235,537 | +6.1% | 657,227 | +16.7% | 0.00% | 0.0% |
| Q4 2022 | $13,412,732 | +25.9% | 563,087 | +4.2% | 0.00% | 0.0% |
| Q3 2022 | $10,657,000 | +23.0% | 540,372 | +21.6% | 0.00% | +33.3% |
| Q2 2022 | $8,662,000 | -23.6% | 444,403 | +0.0% | 0.00% | 0.0% |
| Q1 2022 | $11,332,000 | +4.4% | 444,212 | +3.0% | 0.00% | 0.0% |
| Q4 2021 | $10,851,000 | -7.4% | 431,078 | +1.2% | 0.00% | -25.0% |
| Q3 2021 | $11,715,000 | +4.0% | 425,840 | +20.0% | 0.00% | 0.0% |
| Q2 2021 | $11,266,000 | -22.0% | 354,942 | +12.7% | 0.00% | -20.0% |
| Q1 2021 | $14,444,000 | +36.6% | 314,806 | +17.9% | 0.01% | +25.0% |
| Q4 2020 | $10,574,000 | +14.9% | 267,071 | +1.0% | 0.00% | 0.0% |
| Q3 2020 | $9,206,000 | +198.9% | 264,539 | +171.2% | 0.00% | +100.0% |
| Q2 2020 | $3,080,000 | +370.2% | 97,531 | +226.4% | 0.00% | – |
| Q1 2020 | $655,000 | – | 29,881 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |